Minireview: Pharmacogenetics and beyond: The interaction of therapeutic response, β-cell physiology, and genetics in diabetes

Endocrinology

Volumn 147, Issue 6, 2006, Pages 2657-2663

  Hattersley, Andrew T ^a   Pearson, Ewan R ^a,b  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIDIABETIC AGENT; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SULFONYLUREA; SULFONYLUREA RECEPTOR 1;

CELL DIFFERENTIATION; CELL FUNCTION; CLINICAL FEATURE; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENDOCRINE CELL; EXOCRINE CELL; GENE EXPRESSION; GENE MUTATION; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; LOW DRUG DOSE; MATURITY ONSET DIABETES MELLITUS; MOLECULAR GENETICS; MONOGENIC DISORDER; NEWBORN DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CELL; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL; TREATMENT RESPONSE;

ANIMALS; DIABETES MELLITUS, TYPE 2; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; ISLETS OF LANGERHANS; MUTATION; PHARMACOGENETICS; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 33646778478     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0152     Document Type: Short Survey

References (74)

1. Royal Society Working Group on Pharmacogenitics 2005 Personalised medicines: hopes and realities. London: Royal Society
2. Hattersley AT 2004 Unlocking the secrets of the pancreatic β cell: man and mouse provide the key. J Clin Invest 114:314-316
3. Tattersall RB 1974 Mild familial diabetes with dominant inheritance. Q J Med 43:339-357
4. Tattersall RB, Fajans SS 1975 Prevalence of diabetes and glucose intolerance in 199 offspring of thirty-seven conjugal diabetic parents. Diabetes 24:452-462
5. Fajans SS, Bell GI, Polonsky KS 2001 Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345: 971-980
6. Stride A, Hattersley AT 2002 Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med 34:207-216
7. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P 1993 Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702
8. Frayling T, Bulman MP, Ellard S, Appleton M, Dronsfield M, Mackie A, Baird J, Kaisaki P, Yamagata K, Bell G, Bain S, Hattersley A 1997 Mutations in the hepatocyte nuclear factor 1α gene are a common cause of maturity-onset diabetes of the young in the United Kingdom. Diabetes 46:720-725
9. Bingham C, Hattersley AT 2004 Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1β. Nephrol Dial Transplant 19:2703-2708
10. Bellanne-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C, Dubois-Laforgue D, Dusselier L, Gautier JF, Jadoul M, Laloi-Michelin M, Jacquesson L, Larger E, Louis J, Nicolino M, Subra JF, Wilhem JM, Young J, Velho G, Timsit J 2005 Large genomic rearrangements in the hepatocyte nuclear factor-1β (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 54:3126-3132
11. Slingerland AS, Hattersley AT 2005 Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment. Ann Med 37:186-195
12. Polak M, Shield J 2004 Neonatal and very-early-onset diabetes mellitus. Semin Neonatol 9:59-65
13. Temple IK, Gardner RJ, Mackay DJ, Barber JC, Robinson DO, Shield JP 2000 Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 49:1359-1366
14. Gardner RJ, Mackay DJ, Mungall AJ, Polychronakos C, Siebert R, Shield JP, Temple IK, Robinson DO 2000 An imprinted locus associated with transient neonatal diabetes mellitus. Hum Mol Genet 9:589-596
15. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT 2004 Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350: 1838-1849
16. Hattersley AT, Ashcroft FM 2005 Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 54:2503-2513
17. Stride A, Vaxillaire M, Tuomi T, Barbetti F, Njolstad PR, Hansen T, Costa A, Conget I, Pedersen O, Sovik O, Lorini R, Groop L, Froguel P, Hattersley AT 2002 The genetic abnormality in the β cell determines the response to an oral glucose load. Diabetologia 45:427-435
18. Sturis J, Kurland IJ, Byrne MM, Mosekilde E, Froguel P, Pilkis SJ, Bell GI, Polonsky KS 1994 Compensation in pancreatic β-cell function in subjects with glucokinase mutations. Diabetes 43:718-723
19. Velho G, Blanche H, Vaxillaire M, Bellanne-Chantelot C, Pardini VC, Timsit J, Passa P, Robert JJ, Weber IT, Marotta D, Pilkis SJ, Lipkind GM, Bell GI, Froguel P 1997 Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 40:217-224
20. Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Froguel P, Hattersley AT 2001 β-Cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1α and glucokinase mutations. Diabetes 50:S101-S107
21. Byrne MM, Sturis J, Clement K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI, Velho G, Froguel P, Polonsky KS 1994 Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 93:1120-1130
22. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S 1998 Mutations in the glucokinase gene of the fetus in reduced birthweight. Nat Genet 19:268-270
23. Spyer G, Ballantyne E, Shepherd M, Allen L, Macleod K, Ellard S, Hattersley AT 2000 Fetal growth is altered by fetal genotype and not insulin treatment of maternal hyperglycaemia in gestational diabetes due to mutations in the glucokinase gene. Diabetic Med 17(Suppl):A40
24. Spyer G, Hattersley AT, Sykes JE, Sturley RH, MacLeod KM 2001 Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am J Obstet Gynecol 185:240-241
25. Guenat E, Seematter G, Philippe J, Temler E, Jequier E, Tappy L 2000 Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations. Diabetes Metab 26:377-384
26. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S, Hattersley AT 2001 β-Cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50:S94-S100
27. Stride A, Ellard S, Clark P, Shakespeare L, Salzmann M, Shepherd M, Hattersley AT 2005 β-Cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1α mutation carriers. Diabetes Care 28:1751-1756
28. Isomaa B, Henricsson M, Lehto M, Forsblom C, Karanko S, Sarelin L, Haggblom M, Groop L 1998 Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 41:467-473
29. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS 1996 Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503-1510
30. Heiervang E, Folling I, Sovik O, Sandnes T, Myrmael T, Moen T, Myking O 1989 Maturity-onset diabetes of the young: studies in a Norwegian family. Acta Paediatr Scand 78:74-80
31. Sovik O, Njolstad P, Folling I, Sagen J, Cockburn BN, Bell GI 1998 Hyperexcitability to sulphonylurea in MODY3. Diabetologia 41:607-608
32. Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT 2000 Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor 1α gene mutations: evidence for pharmacogenetics in diabetes. Diabetic Med 17:543-545
33. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT 2003 Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362:1275-1281
34. Shepherd M, Pearson ER, Houghton J, Salt G, Ellard S, Hattersley AT 2003 No deterioration in glycemic control in HNF1α maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 26:3191-3192
35. Shepherd M, Hattersley AT 2004 'I don't feel like a diabetic any more': the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing. Clin Med 4:144-147
36. Sagen JV, Pearson ER, Johansen A, Spyer G, Sovik O, Pedersen O, Njolstad PR, Hattersley AT, Hansen T 2005 Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1α mutation carriers. Diabetic Med 22:406-409
37. Dukes ID, Sreenan S, Roe MW, Levisetti M, Zhou YP, Ostrega D, Bell GI, Pontoglio M, Yaniv M, Philipson L, Polonsky KS 1998 Defective pancreatic β-cell glycolytic signaling in hepatocyte nuclear factor-1α-deficient mice. J Biol Chem 273:24457-24464
38. Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, Polonsky KS 1998 Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J Clin Invest 101:2215-2222
39. Shih DQ, Screenan S, Munoz KN, Philipson L, Pontoglio M, Yaniv M, Polonsky KS, Stoffel M 2001 Loss of HNF1α function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50:2472-2480
40. Wang H, Antinozzi PA, Hagenfeldt KA, Maechler P, Wollheim CB 2000 Molecular targets of a human HNF1α mutation responsible for pancreatic β-cell dysfunction. EMBO J 19:4257-4264
41. Wang H, Maechler P, Hagenfeldt KA, Wollheim CB 1998 Dominant-negative suppression of HNF1α function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic β-cell line. EMBO J 17:6701-6713
42. Wollheim CB 2000 β-Cell mitochondria in the regulation of insulin secretion: a new culprit in type II diabetes. Diabetologia 43:265-277
43. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn B, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahar T, Iwamoto Y, Bell GI 1997 Mutation in hepatocyte nuclear factor-1b gene (TCF2) associated with MODY. Nat Genet 17:384-385
44. Beards F, Frayling T, Bulman M, Horikawa Y, Allen L, Appleton M, Bell GI, Ellard S, Hattersley AT 1998 Mutations in hepatocyte nuclear factor 1β are not a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 47:1152-1154
45. Edghill EL, Bingham C, Ellard S, Hattersley AT 2006 Mutations in hepatocyte nuclear factor-1β and their related phenotypes. J Med Genet 43:84-90
46. Bingham C, Ellard S, Allen L, Bulman M, Shepherd M, Frayling T, Berry PJ, Clark PM, Lindner T, Bell GI, Ryffel GU, Nicholls AJ, Hattersley AT 2000 Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1β. Kidney Int 57:898-907
47. Bingham C, Bulman MP, Ellard S, Allen LI, Lipkin GW, Hoff WG, Woolf AS, Rizzoni G, Novelli G, Nicholls AJ, Hattersley AT 2001 Mutations in the hepatocyte nuclear factor-1β gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 68:219-224
48. Bingham C, Ellard S, Cole TR, Jones KE, Allen LI, Goodship JA, Goodship TH, Bakalinova-Pugh D, Russell GI, Woolf AS, Nicholls AJ, Hattersley AT 2002 Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1β mutations. Kidney Int 61:1243-1251
49. Bingham C, Ellard S, van't Hoff WG, Simmonds HA, Marinaki AM, Badman MK, Winocour PH, Stride A, Lockwood CR, Nicholls AJ, Owen KR, Spyer G, Pearson ER, Hattersley AT 2003 Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1β gene mutation. Kidney Int 63:1645-1651
50. Harries LW, Ellard S, Jones RW, Hattersley AT, Bingham C 2004 Abnormal splicing of hepatocyte nuclear factor-1β in the renal cysts and diabetes syndrome. Diabetologia 47:937-942
51. Pearson ER, Badman MK, Lockwood CR, Clark PM, Ellard S, Bingham C, Hattersley AT 2004 Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1α and -1β mutations. Diabetes Care 27:1102-1107
52. Brackenridge A, Pearson ER, Shojaee-Moradie F, Hattersley AT, Russell-Jones D, Umpleby AM 2006 Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1β and -1α mutations. Diabetes 55:405-411
53. Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, Wilhelm JM, Boitard C, Noel LH, Velho G, Timsit J 2004 Clinical spectrum associated with hepatocyte nuclear factor-1β mutations. Ann Intern Med 140:510-517
54. Maestro MA, Boj SF, Luco RF, Pierreux CE, Cabedo J, Servitja JM, German MS, Rousseau GG, Lemaigre FP, Ferrer J 2003 Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas. Hum Mol Genet 12:3307-3314
55. Yorifuji T, Kurokawa K, Mamada M, Imai T, Kawai M, Nishi Y, Shishido S, Hasegawa Y, Nakahata T 2004 Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1β gene due to germline mosaicism. J Clin Endocrinol Metab 89:2905-2908
56. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S, Hattersley AT 2001 β-Cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50:S94-S100
57. Gloyn AL, Reimann F, Girard C, Edghill EL, Proks P, Pearson ER, Temple IK, Mackay DJ, Shield JP, Freedenberg D, Noyes K, Ellard S, Ashcroft FM, Gribble FM, Hattersley AT 2005 Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum Mol Genet 14:925-934
58. Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT, Ashcroft FM 2004 Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci USA 101:17539-17544
59. Proks P, Girard C, Haider S, Gloyn AL, Hattersley AT, Sansom MS, Ashcroft FM 2005 A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. EMBO Rep 6:470-475
60. Codner E, Flanagan S, Ellard S, Garcia H, Hattersley AT 2005 High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in earlyonset diabetes caused by a novel R201L Kir6.2 mutation. Diabetes Care 28: 758-759
61. Klupa T, Edghill EL, Nazim J, Sieradzki J, Ellard S, Hattersley AT, Malecki MT 2005 The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of β cell function among carriers of the R201H mutation. Diabetologia 48:1029-1031
62. Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, Baevre H, Abuelo D, Phornphutkul C, Molnes J, Bell G, Gloyn AL, Hattersley AT, Molven A, Sovik O, Njolstad PR 2004 Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53:2713-2718
63. Zung A, Glaser B, Nimri R, Zadik Z 2004 Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 89:5504-5507
64. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl M-C, Nemesh J, Lane CR, Schaffner F, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES 2000 The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
65. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, Levy JC, Sampson M, Halford S, McCarthy MI, Hattersley AT, Frayling TM 2003 Large-scale association studies of variants in genes encoding the pancreatic β-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52:568-572
66. Florez J, Burtt N, de Bakker P, Almgren P, Tuomi T, Holmkvist J, Gaudet D, Hudson T, Schaffner S, Daly M, Hirschhorn J, Groop L, Altshuler D 2004 Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 53:1360-1368
67. Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Magnuson MA, Chu CA, Dvorozniak MT, Matschinsky FM, Grippo JF 2003 Allosteric activators of glucokinase: potential role in diabetes therapy. Science 301:370-373
68. Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, Doliba N, Han Y, Taub R, Grimsby J 2006 The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55:1-12
69. Hattersley AT, Turner RC, Permutt MA, Patel P, Tanizawa Y, Chiu KC, O'Rahilly S, Watkins PJ, Wainscoat JS 1992 Linkage of type 2 diabetes to the glucokinase gene. Lancet 339:1307-1310
70. Njolstad P, Sovik O, Cuesta-Munoz A, Bjorkhaug L, Massa O, Barbetti F, Undlien D, Shiota C, Magnuson M, Molven A, Matschinsky F, Bell G 2001 Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588-1592
71. Glaser B, Kesavan P, Haymen M, Davies E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM, Herold KC 1998 Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338:226-230
72. Gloyn AL, Noordam K, Willemsen MA, Ellard S, Lam WW, Campbell IW, Midgley P, Shiota C, Buettger C, Magnuson MA, Matschinsky FM, Hattersley AT 2003 Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes 52: 2433-2440
73. Weedon MN, Frayling TM, Shields B, Knight B, Turner T, Metcalf BS, Voss L, Wilkin TJ, McCarthy A, Ben-Shlomo Y, Davey Smith G, Ring S, Jones R, Golding J, Byberg L, Mann V, Axelsson T, Syvanen AC, Leon D, Hattersley AT 2005 Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene. Diabetes 54:576-581
74. Raeder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V, Nermoen I, Eide SA, Grevle L, Bjorkhaug L, Sagen JV, Aksnes L, Sovik O, Lombardo D, Molven A, Njolstad PR 2006 Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 38:54-62